http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
CENTOGENE and Evotec Sign Global Strategic Partnership on Drug Discovery Projects in Rare Genetic Diseases
-
Evotec Forms Academic Bridge 'LAB591' with Arix Bioscience and Fred Hutchinson Cancer Research Center
-
Evotec and Celgene (CELG) Expand IPSC Collaboration to Include Additional Cell Lines
-
Evotec and Celgene Expand IPSC Collaboration to Include Additional Cell Lines
-
Evotec and Celgene (CELG) Enter into Strategic Oncology Partnership
-
Evotec and Celgene Enter into Strategic Oncology Partnership
-
Evotec Reports First Quarter 2018 Results and Provides Corporate Update
-
Evotec and Carna Biosciences Collaborate on Indigo Platform
-
Evotec to Present at Upcoming Investor Conferences
-
Evotec AG to Report First Quarter 2018 Results on 09 May 2018
-
Evotec Expands CRISPR-Based Technology Offering with Licence from ERS Genomics
-
Evotec and Bayer Advance Third Endometriosis Programme into Phase I Clinical Development
-
Evotec Forms Collaboration with Petra Pharma on Indigo Platform
-
Evotec AG Fiscal Year 2017 Results: Leading External Innovation
-
Evotec Launches INDIGO, A Unique Integrated Drug Development Solution for Accelerating Early Drug Candidates into the Clinic
-
Evotec AG to Report Fiscal Year 2017 Results on 28 March 2018
-
Evotec and Sanofi in Exclusive Talks to Create an Evotec-Led Infectious Disease Open Innovation R&D Platform
-
Evotec to Attend Upcoming Investor Conferences
-
Evotec and MaRS Innovation Announce First Funded Project under LAB150 Bridge
-
APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi
-
Evotec and Apeiron Achieve First Milestone in Immuno-Oncology Alliance with Sanofi
-
Evotec to Attend Upcoming Investor Conferences
-
Evotec Enters into Research Collaboration with CRTD to Discover Novel Therapies for Retinal Diseases
-
Evotec's Academic Bridge LAB282 with Oxford University Celebrating One Year of Impact
-
EVOTEC RECEIVES CLINICAL MILESTONE AS PART OF ITS DISCOVERY ALLIANCE WITH BOEHRINGER INGELHEIM
-
Evotec to Attend Upcoming Investor Conferences
-
Evotec AG Announces First Nine-Month 2017 Results and Corporate Update
-
Evotec Joins Forces with Academic Leaders to Accelerate Drug Discovery in Kidney Diseases and Build 'NEPLEX'
-
Evotec AG to Report First Nine-Month 2017 Results on 08 November 2017
-
Evotec and TESARO Enter Strategic Partnership to Discover Novel Immuno-Oncology Agents
-
Evotec Invests in Exscientia to Advance AI-Driven Drug Discovery
-
European Investment Bank Supports Evotec's Innovate Strategy with EUR 75 M Loan
-
Evotec and ABIVAX Enter into Strategic Collaboration to Develop Novel Antiviral Agents
-
Evotec to Attend Upcoming Investor Conferences
-
Evotec Completes Acquisition of Aptuit
-
Evotec Announces First Half Year 2017 Results and Corporate Update
-
Evotec AG to Report First Half-Year 2017 Results on 10 August 2017
-
Evotec and Fraunhofer IME-SP Sign Strategic Collaboration on IPSC Technology
-
Evotec to Acquire Aptuit, Expanding Leadership in External Innovation
-
Evotec Expands Collaboration with Storm Therapeutics on Its RNA Epigenetics Platform
-
Evotec and Bayer Advance Endometriosis Programme into Phase I Clinical Development and Extend Alliance
-
Evotec Received Funding from IFB Hamburg to Identify Antibody-Mediated T-cell Immunotherapies
-
Evotec Expands iPSC Drug Discovery Leadership Through Strategic Collaboration with Censo Biotechnologies
-
Evotec AG: LAB282 Accelerates with Second Round Funding
-
Evotec Announces Strategic Investment in Facio Therapies to Support Development of Novel FSHD Therapy
-
Resolutions of the Annual General Meeting 2017 of Evotec AG
-
Evotec Joins NURTuRE Consortium to Mine Unique Kidney Disease Patient Biobank
-
Evotec Receives Pre-Clinical Milestone as Part of Its Endometriosis Alliance with Bayer
-
Forge Therapeutics Attracts Biotechnology Leaders To Join Expanded Board Of Directors
-
Evotec to Attend Three Upcoming Investor Conferences

